Zdrowie i gospodarka · 20/04/2000

FDA Amends Conditions for Marketing Parenteral Multivitamin Products

The Food and Drug Administration (FDA) is updating the conditions for marketing an effective adult parenteral multivitamin drug product, which was previously published in the Federal Register on September 17, 1984 (49 FR 36446). The agency is informing manufacturers of changes to the adult formulation and certain labeling sections for the products.